Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Goodnight

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Annals of Internal Medicine|June 1, 1983
Dimethyl sulfoxide and extravasation of anthracycline agentsH J Lawrence, S H Goodnight
The Western Journal of Medicine|July 10, 1998
Factors V Leiden and the prothrombin gene mutation: two common genetic defects associated with thrombosisJ L Kujovich, S H Goodnight
Chest|October 1, 1995
Therapeutic use of n-3 fatty acids for vascular disease and thrombosisS H Goodnight, J A Cairns
The Western Journal of Medicine|May 1, 1995
Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein CR D Press, S H Goodnight
American Journal of Surgery|August 1, 1977
The clinical use of fibrinolytic agentsJ M Porter, S H Goodnight
Seminars in Vascular Surgery|March 1, 1993
The hypercoagulable states: diagnosis and managementT G DeLoughery, S H Goodnight
Seminars in Oncology|April 1, 1990
Bleeding disorders in cancerF S Ey, S H Goodnight
American Journal of Surgery|August 1, 1977
The role of the platelet in coagulation and clinical thrombotic eventsJ M Porter, S H Goodnight
The American Journal of Physiology|May 1, 1975
Fibrinogen levels after inflammation or endotoxin in normal and hypophysectomized ratsS H Goodnight, S I Rapaport, A Zivelin
American Journal of Clinical Pathology|May 1, 1980
Measurement of antithrombin III in normal and pathologic states using chromogenic substrate S-2238. Comparison with immunoelectrophoretic and factor Xa inhibition assaysS H Goodnight, J L Schaeffer, K Sheth
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Annals of Internal Medicine|June 1, 1983
Dimethyl sulfoxide and extravasation of anthracycline agentsH J Lawrence, S H Goodnight
The Western Journal of Medicine|July 10, 1998
Factors V Leiden and the prothrombin gene mutation: two common genetic defects associated with thrombosisJ L Kujovich, S H Goodnight
Chest|October 1, 1995
Therapeutic use of n-3 fatty acids for vascular disease and thrombosisS H Goodnight, J A Cairns
The Western Journal of Medicine|May 1, 1995
Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein CR D Press, S H Goodnight
American Journal of Surgery|August 1, 1977
The clinical use of fibrinolytic agentsJ M Porter, S H Goodnight
Seminars in Vascular Surgery|March 1, 1993
The hypercoagulable states: diagnosis and managementT G DeLoughery, S H Goodnight
Seminars in Oncology|April 1, 1990
Bleeding disorders in cancerF S Ey, S H Goodnight
American Journal of Surgery|August 1, 1977
The role of the platelet in coagulation and clinical thrombotic eventsJ M Porter, S H Goodnight
The American Journal of Physiology|May 1, 1975
Fibrinogen levels after inflammation or endotoxin in normal and hypophysectomized ratsS H Goodnight, S I Rapaport, A Zivelin
American Journal of Clinical Pathology|May 1, 1980
Measurement of antithrombin III in normal and pathologic states using chromogenic substrate S-2238. Comparison with immunoelectrophoretic and factor Xa inhibition assaysS H Goodnight, J L Schaeffer, K Sheth
Pageof 7